2021-2022 Regular Session • Minnesota Legislature
HF633
Legislative Summary
Individual and small group health plan offerings required to include predeductible, flat co-pay on prescription drug option.
Demographic Impact
Overall analysis of equity impact
70% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/1/2021
Introduction and first reading, referred to Commerce Finance and Policy
House of Representatives
2/4/2021
Authors added Hamilton, Long and Christensen
House of Representatives
2/8/2021
Author added Hanson, J.
House of Representatives
2/10/2021
Author added Edelson
House of Representatives
2/11/2021
Author added Olson, L.
House of Representatives
2/15/2021
Author added Huot
House of Representatives
2/18/2021
Author added Boe
House of Representatives
2/22/2021
Authors added Elkins and Lee
House of Representatives
2/25/2021
Committee report, to adopt as amended and re-refer to Health Finance and Policy
House of Representatives
3/1/2021
Author added Reyer
House of Representatives
2/24/2022
Author added Davids
House of Representatives
3/10/2022
Author added Feist
House of Representatives
3/28/2022
Author stricken Davids
House of Representatives
3/30/2022
Committee report, to adopt as amended
House of Representatives
3/30/2022
Second reading
House of Representatives
Status Information
Current Status
Introduced(2/1/2021)
Chamber
House of Representatives
Sine Die
Sponsors
Democrat: 11
Republican: 2
Primary Sponsor
Robert Bierman
Democrat